- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01789307
Lactose, Sucrose & Corn Syrup Tolerance
Lactose: A Unique Carbohydrate Enabling Homeostatic Regulation of Blood Glucose & Insulin
Lactose, one of the key nutrients in human milk may be critically important to infants for more reasons than being a source of energy. We are interested in understanding how lactose when compared to other sugars influences how nutrients, specifically macronutrients are handled after digestion and absorption. To date, there have been no studies looking at how fat and protein varies when lactose compared to other sugars is ingested. There may be metabolic advantages to considering lactose for nutrition support of premature infants rather than glucose or dextrose as is often used in intravenous feeds, or the corn syrup solids in lactose-free formulas. We hope the information from this study will provide new information on the unique aspects of lactose.
Hypothesis: The hypothesis is that providing carbohydrate as lactose:
- minimizes the amount of carbohydrate that is converted into fat
- enables a relatively constant metabolic state throughout feeding interval that avoids swings of high to low insulin, glucose, and fats.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z4H4
- Child & Family Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male
- at least 19 years of age
- body mass index (BMI) between 18.5 and 25
- fasting blood glucose level < 6.1 mmol/L (110 mg/dL) measured by glucometer on the day of the study and
- comfortable speaking, reading and understanding English
- comfortable drinking at least one cup (250 ml) of milk
- non-smoking
Exclusion Criteria:
- not willing to provide blood samples, have
- impaired lactose or glucose tolerance,
- pre-diabetes, diabetes mellitus and any other endocrine disorder,
- coronary heart disease, liver function test abnormalities or any chronic disease
- routinely take medications, including aspirin, cyclooxygenase-2 inhibitors, statins and fish oil
- consuming more than 1 alcoholic drink per day
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: corn syrup solids
corn syrup solids oral ingestion
|
oral ingestion 50 grams, 2 doses
Other Names:
|
Experimental: sucrose
sucrose oral ingestion
|
oral ingestion 50 grams, 2 doses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial changes in plasma insulin, glucagon, triglycerides and amino acids.
Time Frame: 6 hours
|
Area under the curve changes in the outcome measures following oral ingestion.
|
6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial changes in plasma fatty acids.
Time Frame: 6 hours
|
Area under the curve analyses of changes in plasma fatty acids following oral ingestion
|
6 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sheila M Innis, PhD, University of British Columbia, Child & Family Research Institute
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H12-01647
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on corn syrup solids
-
Washington University School of MedicineCompleted
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI); University of Southern California and other collaboratorsCompletedObesity | Type 2 Diabetes | Chronic Disease of Cardiovascular SystemUnited States
-
John SievenpiperCanadian Diabetes Association; The Physicians' Services Incorporated Foundation and other collaboratorsUnknownObesity | Overweight | Body Weight | Adiposity | Obesity, AbdominalCanada
-
University of TorontoCanadian Institutes of Health Research (CIHR); Canadian Diabetes Association; The Physicians' Services Incorporated FoundationUnknownCardiovascular Diseases | Stroke | Hypertension | Diabetes Mellitus, Type 2 | Gout | Metabolic Syndrome XCanada
-
University of TorontoCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated... and other collaboratorsUnknownHypertension | Obesity | Cardiovascular Disease | Dyslipidemia | Prediabetes | Gout | Non-Alcoholic Fatty Liver Disease | DysglycemiaCanada
-
University of TorontoCompletedAbdominal ObesityCanada
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); University of WashingtonCompletedObesity | Cardiovascular Disease | Type 2 Diabetes Mellitus | Intestinal Permeability | Low-grade Chronic InflammationUnited States
-
UCSF Benioff Children's Hospital OaklandAlmond Board of CaliforniaCompleted
-
USDA Grand Forks Human Nutrition Research CenterCompleted